Literature DB >> 23110467

The Kallikrein-Kinin system.

P Hillmeister1, P B Persson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23110467     DOI： 10.1111/apha.12007

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN： 1748-1708            Impact factor:   6.311


× No keyword cloud information.
  15 in total

1.  Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection.

Authors:  Kritika Ramani; Chetan V Jawale; Akash H Verma; Bianca M Coleman; Jay K Kolls; Partha S Biswas
Journal:  JCI Insight       Date:  2018-05-03

2.  Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.

Authors:  Libor Kopkan; Zuzana Husková; Šárka Jíchová; Lenka Červenková; Luděk Červenka; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Clin Exp Hypertens       Date:  2015-07-07       Impact factor: 1.749

3.  The molecular basis of subtype selectivity of human kinin G-protein-coupled receptors.

Authors:  Lisa Joedicke; Jiafei Mao; Georg Kuenze; Christoph Reinhart; Tejaswi Kalavacherla; Hendrik R A Jonker; Christian Richter; Harald Schwalbe; Jens Meiler; Julia Preu; Hartmut Michel; Clemens Glaubitz
Journal:  Nat Chem Biol       Date:  2018-01-15       Impact factor: 15.040

4.  Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment.

Authors:  Amaly Nokkari; Tarek H Mouhieddine; Muhieddine M Itani; Wassim Abou-Kheir; Georges Daoud; Rui Zhu; Yehia Mechref; Yehia Meshref; Jihane Soueid; Moustafa Al Hariri; Stefania Mondello; Ayad A Jaffa; Firas Kobeissy
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

5.  Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1.

Authors:  Lilia Maneva-Radicheva; Christina Amatya; Camille Parker; Jacob Ellefson; Ilian Radichev; Arvind Raghavan; Matthew L Charles; Mark S Williams; Mark S Robbins; Alexei Y Savinov
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

6.  The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney.

Authors:  Kritika Ramani; Abhishek V Garg; Chetan V Jawale; Heather R Conti; Natasha Whibley; Edwin K Jackson; Sruti S Shiva; William Horne; Jay K Kolls; Sarah L Gaffen; Partha S Biswas
Journal:  PLoS Pathog       Date:  2016-11-04       Impact factor: 6.823

Review 7.  Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).

Authors:  Marina Devetzi; Maria Goulielmaki; Nicolas Khoury; Demetrios A Spandidos; Georgia Sotiropoulou; Ioannis Christodoulou; Vassilis Zoumpourlis
Journal:  Int J Mol Med       Date:  2018-01-03       Impact factor: 4.101

Review 8.  Proteolytic activity of contact factor zymogens.

Authors:  Aleksandr Shamanaev; Jonas Emsley; David Gailani
Journal:  J Thromb Haemost       Date:  2020-12-07       Impact factor: 5.824

9.  Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Authors:  Tadeusz Kolodka; Matthew L Charles; Arvind Raghavan; Ilian A Radichev; Christina Amatya; Jacob Ellefson; Alexei Y Savinov; Abhijeet Nag; Mark S Williams; Mark S Robbins
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

10.  Tissue Kallikrein Exacerbating Sepsis-Induced Endothelial Hyperpermeability is Highly Predictive of Severity and Mortality in Sepsis.

Authors:  Xiao Ran; Qin Zhang; Shaoping Li; Zhen Yu; Li Wan; Bin Wu; Rongxue Wu; Shusheng Li
Journal:  J Inflamm Res       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.